Anemia in patients with type 2 diabetes mellitus and its association with the microvascular complications

https://doi.org/10.53730/ijhs.v6nS9.13574

Authors

  • Anjaly. V.P Senior Resident, Department of General Medicine, Government Medical College Kottayam, Kerala
  • Sanghamithra. P Professor, Department of General Medicine, Government Medical College Kottayam, Kerala
  • Lijo. K. Mathew Associate Professor, Department of Genereal Medicine, Government Medical College Kottayam, Kerala

Keywords:

Diabetes mellitus, Anemia, Microvascular complications, Diabetic retinopathy, Diabetic neuropathy, Diabetic nehpropathy

Abstract

Introduction: Anemia is more commonly seen in persons with diabetes than in persons without diabetes. There is high risk of microvascular and macrovascular complications in diabetes. Anemia is strongly associated with an increased risk of diabetic complications including nephropathy, retinopathy, neuropathy and heart failure. Aim of the study: To assess the correlation between anemia and the microvascular complications of diabetes mellitus. Materials and Methods: This was a prospective, cross sectional, hospital based study conducted in department of General Medicine at Government Medical College, Kottayam, over a period of one year. Two hundred consecutive cases of diabetes mellitus with anemia were studied for microvascular complications like diabetic neuropathy, nephropathy, retinopathy. Results: Total 200 patients were enrolled with 116 (58%) male and 84 (42%) female patients and male to female ratio was 1.3:1. The patient age ranged from 41 to 86 years and mean age was 60.78±9.38 years. Diabetic neuropathy was absent in 38% and present in 62%. Proliferative and nonproliferative diabetic retinopathy was seen in 18% and 53% cases respectively. Conclusion: Anemia has correlation with the microvascular complications of diabetes. With increasing duration of diabetes mellitus the hemoglobin levels fall progressively.

Downloads

Download data is not yet available.

References

Stumvoll M, Goldstein BJ, van Haeften TW. Type 2 diabetes: principles of pathogenesis and therapy. Lancet Lond Engl. 2005 Apr 9; 365(9467):1333–46.

Robertson RP. Antagonist: diabetes and insulin resistance--philosophy, science, and the multiplier hypothesis. J Lab Clin Med. 1995 May; 125(5):560–4; discussion 565.

Camargo JL, Gross JL. Conditions associated with very low values of glycohaemoglobin measured by an HPLC method. J Clin Pathol. 2004 Apr 1; 57(4):346–9.

Ranil PK, Raman R, Rachepalli SR, Pal SS, Kulothungan V, Lakshmipathy P, Satagopan U, Kumaramanickavel G, Sharma T. Anemia and diabetic retinopathy in type 2 diabetes mellitus. J Assoc Physicians India. 2010 Feb; 58:91-4.

Hosseini MS, Rostami Z, Saadat A, Saadatmand SM, Naeimi E. Anemia and Microvascular Complications in Patients With Type 2 Diabetes Mellitus.

Mohan VA, Nithyanandam S, Idiculla J. Microalbuminuria and low hemoglobin as risk factors for the occurrence and increasing severity of diabetic retinopathy. Indian J Ophthalmol. 2011; 59(3):207–10.

Willis JR, Doan QV, Gleeson M, Haskova Z, Ramulu P, Morse L, et al. Vision Related Functional Burden of Diabetic Retinopathy Across Severity Levels in the United States. JAMA Ophthalmol. 2017 01; 135(9):926–32.

Smith AG, Singleton JR. Obesity and hyperlipidemia are risk factors for early diabetic neuropathy. J Diabetes Complications. 2013 Oct; 27(5):436–42.

Shai I, Jiang R, Manson JE, Stampfer MJ, Willett WC, Colditz GA, et al. Ethnicity, obesity, and risk of type 2 diabetes in women: a 20-year follow-up study. Diabetes Care. 2006 Jul; 29(7):1585–90.

Hostetter TH. Hyperfiltration and glomerulosclerosis. Semin Nephrol. 2003 Mar; 23(2):194–9.

Tonneijck L, Muskiet MHA, Smits MM, van Bommel EJ, Heerspink HJL, van Raalte DH, et al. Glomerular Hyperfiltration in Diabetes: Mechanisms, Clinical Significance, and Treatment. J Am Soc Nephrol JASN. 2017; 28(4):1023-39.

Pichler R, Afkarian M, Dieter BP, Tuttle KR. Immunity and inflammation in diabetic kidney disease: translating mechanisms to biomarkers and treatment targets. Am J Physiol Renal Physiol. 2017 01; 312(4):F716–31.

Hojs R, Ekart R, Bevc S, Hojs N. Markers of Inflammation and Oxidative Stress in the Development and Progression of Renal Disease in Diabetic Patients. Nephron. 2016; 133(3):159–62.

Published

30-09-2022

How to Cite

Anjaly, V. P., Sanghamithra, P., & Mathew, L. K. (2022). Anemia in patients with type 2 diabetes mellitus and its association with the microvascular complications. International Journal of Health Sciences, 6(S9), 4030–4043. https://doi.org/10.53730/ijhs.v6nS9.13574

Issue

Section

Peer Review Articles